Highlights
1 patentProfile claimed by owner
About
Microbiome Drug Discovery System
RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science. The proprietary, cloud-based computational pipeline uses raw metagenomics to derive both static and dynamic strain-level insights into the bacterial ecosystem.
Identity
| Name | RondinX |
|---|---|
| Slug | rondinx |
| Type / kind | startup |
| Crunchbase ID | rondinx |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMe4qokLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by BiomX on Dec 2017 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat HaSharon |
| HQ address | HaKfar HaYarok, Ramat Hasharon, Israel |
Web & social
| https://www.linkedin.com/company/7972893 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
microbiologygenomicsbiotechnologybioinformaticsbacteriamicrobiomenovel-ingredientsprecision-medicinepharma-companies
Funding
| Total raised | $2.5M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}